5-Chloromethyl-3-(4-fluoro-phenyl)-[1,2,4]oxadiazole, 97.0%, 5g

Sample tub Type 2116, 1000 ml, 4 Piece(s)

(R)-(1-Boc-Pyrrolidin-3-yl)-acetic acid, 97.0%, 1g

2-(2-Bromophenyl)-2-methylpropanenitrile, 95.0%, 5g

3-METHYL-4-(TRIFLUOROMETHYL)PIPERIDIN-4-OL HCL, 95.0%, 250mg

2-(Trifluoromethyl)quinoxaline, 1g

tert-Butyl ((3S,5S)-5-(trifluoromethyl)piperidin-3-yl)carbamate, 98%, 100mg

C-(7-METHYL-[1,2,4]TRIAZOLO[4,3-A]PYRIDIN-3-YL)-METHYLAMINE, 95.0%, 100mg

2-Nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 500mg

(1S)-2,2',3,3'-Tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diamine, 98%, 1g

1-BENZHYDRYL-3-CHLORO-3-METHYLAZETIDINE, 95.0%, 5g

HEXAMETHYLENE OXIDE, 95%, 250mg

3-Iodobenzene-1,2-diol, 95.0%, 1g